We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for maribavir (Takeda Pharmaceuticals Australia Pty Ltd)
Active ingredients
maribavir
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of cytomegalovirus infection and/or disease in patients with impaired cell-mediated immunity
Therapeutic area
Infectious diseases